LivaNova LIVN
NASDAQ LIVN
$78.00 -2.84 (-3.51%)
At close: Aug 20, 2026 · 1:33 PM UTC

LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026)

LivaNova (LIVN) posted Other Non-Current Liabilities of $54.4 million for Q1 2026, up 29.34% sequentially from $42.0 million in Q4 2025, and up 14.98% YoY from $47.3 million in Q1 2025.

LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends

LivaNova has reported Other Non-Current Liabilities for 12 years, with the latest figure at $54.4 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 14.98% year-over-year to $54.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (up 14.98% YoY) and the FY2025 annual result came in at $42.0 million, down 5.47% from the prior year.
  • Other Non-Current Liabilities advanced to $54.4 million in Q1 2026 per LIVN's latest filing, from $42.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $104.9 million in Q1 2024 and troughed at $39.7 million in Q2 2025.
  • A 5-year average of $59.8 million and a median of $47.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities slumped 59.28% in 2022, then soared 126.76% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $85.3 million in 2022, then declined by 5.15% to $80.9 million in 2023, then sank by 45.02% to $44.5 million in 2024, then retreated by 5.47% to $42.0 million in 2025, then climbed by 29.34% to $54.4 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $54.4 million, $42.0 million, and $64.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.93 Bn 193.33 Bn 7.27 Bn
2 Stryker 127.82 Bn 124.35 Bn 4.50 Bn
3 Medtronic 118.80 Bn 109.58 Bn 6.41 Bn
4 Boston Scientific 73.38 Bn 72.84 Bn 3.85 Bn
5 Edwards Lifesciences 51.95 Bn 47.70 Bn 1.35 Bn
6 Dexcom 34.44 Bn 32.50 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.80 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.10 Bn 22.62 Bn 684.20 Mn
10 LivaNova 4.29 Bn 3.77 Bn 273.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 152.90 Mn
Mar 31, 2026 54.38 Mn
Dec 31, 2025 42.05 Mn
Sep 30, 2025 64.52 Mn
Jun 30, 2025 39.66 Mn
Mar 31, 2025 47.29 Mn
Dec 31, 2024 44.48 Mn
Sep 30, 2024 47.04 Mn
Jun 30, 2024 81.17 Mn
Mar 31, 2024 104.92 Mn
Dec 31, 2023 80.90 Mn
Sep 30, 2023 46.26 Mn
Jun 30, 2023 92.63 Mn
Mar 31, 2023 46.27 Mn
Dec 31, 2022 85.29 Mn
Sep 30, 2022 42.39 Mn
Jun 30, 2022 47.19 Mn
Mar 31, 2022 49.77 Mn
Dec 31, 2021 86.83 Mn
Sep 30, 2021 104.08 Mn